Treatment of freshly isolated acute promyelocytic leukemia (APL) cells
and the myelogenous leukemia cell lines, NB4, HL-60, and U937, with a
ll-trans retinoic acid (ATRA) results in a remarkable elevation in the
amounts of Stat1 alpha and Stat2 proteins. Stat1 alpha protein levels
are augmented by ATRA as a consequence of elevated amounts of the cor
responding transcripts. The retinoid increases the levels of nuclear c
omplexes that are capable of binding to interferon (IFN)-regulated con
sensus sequences and contain Stat1 and/or Stat2 proteins, and causes a
rapid and long-lasting elevation in Stat1 alpha tyrosine phosphorylat
ion. Transient transfection experiments show that ATRA enhances the tr
ansactivating properties of Stat1 alpha observed on an appropriate rep
orter gene, in the presence of the RAR alpha retinoic acid receptor, b
ut not in the presence of the PML-RAR protein. Treatment of NB4 cells
with ATRA is associated with a remarkable upregulation of the two IFN-
responsive genes IFN-responsive factor 1 and 2'-5' oligoadenylate synt
hetase, as well as with an augmentation in the levels of IFN alpha sec
retion. Our data show that ATRA is capable of modulating the amounts a
nd the state of activation of some of the components of the IFN intrac
ellular signaling pathways. They also suggest that the retinoid can by
pass IFN/IFN-receptor interactions and induce the expression of IFN-re
gulated genes. (C) 1997 by The American Society of Hematology.